Go Far
Go Far is a Portuguese joint venture between Méis (Grupo Ageas) and the Associação Nacional das Farmácias that delivers insurance-funded primary healthcare services — including cardiology diagnostics, chronic-disease monitoring, and preventive screening — through Portugal's roughly 3,000-pharmacy community network.
- Company typePrivate
- Founded2017
- HeadquartersLisboa, Portugal
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Go Far does
Go Far is a Portuguese health services joint venture founded in 2017 by Grupo Ageas Portugal, through its health insurance subsidiary Méis (Serviços de Saúde, S.A.), and the Associação Nacional das Farmácias (ANF). Operating from Lisbon, the company runs a service-coordination platform that integrates the Farmácias Portuguesas network — Portugal's most geographically distributed primary-care channel of roughly 3,000 community pharmacies — with the Méis health insurance product line. Its portfolio spans cardiology diagnostics (MCDT Cardiologia: ECG, 24-hour MAPA blood pressure monitoring, 24-hour Holter), chronic-disease monitoring (HbA1c, lipid profile, INR/anticoagulant control), vaccination administration, injectable administration, medication home delivery, orthopaedics for Ageas accident victims, and national preventive-screening campaigns (diabetes and the 2021 'Campanha 50+' colorectal cancer screening that reached 4,190 participants through 292 pharmacies). Cardiology reporting is delivered via a partnership with Clínica de Cardiologia Dr. Machado Lemos.
The business model combines two regulated revenue streams. First, Go Far is registered with the Portuguese insurance supervisor (ASF) as a Mediação de Seguros, generating commissions from Méis for mediating insurance products and pharmacy-channel health services to roughly 700,000 Méis policyholders. Second, the company collects pharmacy network management and service-enablement fees from the approximately 800 pharmacies integrated into the Rede Méis, which provides automatic insurance reimbursement on services such as vaccination, injectables, INR monitoring, and cardiology diagnostics. A separate, non-recurring revenue layer comes from co-funded screening campaigns, with sponsorship drawn from Fundação Ageas, Fundação Calouste Gulbenkian, Fundação Millennium bcp, and the patient-advocacy group Europacolon Portugal. The go-to-market is B2B2C: pharmacies are recruited via a formal adhesion process on go-far.pt, then serve end-consumers (both Méis insureds and the broader Portuguese population) with insurance-financed or fee-based access.
Despite a national service footprint, Go Far runs with a deliberately small in-house team (1–10 employees) and operates within a tightly held two-shareholder JV structure that has not changed since founding; registered share capital is €550,000. Governance is exercised by a six-member Board of Directors chaired by Ema Paulino Pires, with Méis CEO Eduardo Pedroso and several ANF-linked directors. Day-to-day leadership rests with CEO Hugo Julião, supported by project managers such as Nuno Pereira dos Reis and Sara Marques. Strategically, the company positions itself as the bridge between Portugal's dominant private health insurer and its dominant pharmacy association, addressing gaps in preventive care access across regions underserved by hospitals and health centres.
Go Far firmographics
Firmographics- Name
- Go Far
- Legal name
- Go Far Insurance - Soluções e Serviços para Protecção da Saúde, Mediação de Seguros, S.A.
- Website
- https://go-far.pt
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Go Far is a Portuguese joint venture between Méis (Grupo Ageas) and the Associação Nacional das Farmácias that delivers insurance-funded primary healthcare services — including cardiology diagnostics, chronic-disease monitoring, and preventive screening — through Portugal's roughly 3,000-pharmacy community network.
- Ownership category
- akta.pro rank
Go Far industry classification
Industry- Product category
- Pharmacy-based Primary Healthcare Services
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Insurance Agencies and Brokerages (524210), Ambulatory Health Care Services (621)
- SIC
- Insurance Agents, Brokers & Service (6411), Services-Health Services (8000)
- akta.pro industry
- Pharmacy Benefit Management (PBM) & Pharmacy Network AdministrationGroup Pharmacy Benefit (Rx) Coverage & PBM-Integrated PlansPharmacy & Health Essentials Delivery
Keywords
Where Go Far is headquartered
LocationHeadquarters
- HQ city
- Lisboa
- HQ country
- Portugal
- HQ region
- Europe
Offices2 records
Markets served
Go Far business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Insurance Mediation Fees: Go Far operates as an insurance mediator (Mediação de Seguros) registered with ASF, generating revenue through commissions from Médis (health insurance subsidiary of Grupo Ageas Portugal) for mediating health insurance products and services to pharmacies and pharmacy customers.
- Pharmacy Network Management Fees: Pharmacies pay to join the Go Far network and access Médis-financed services, creating a recurring revenue stream from network membership and service enablement fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Colorectal cancer screening kit at nominal cost for general population |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Go Far product offering
Product offeringCore offering
Go Far operates as an insurance mediator (Mediação de Seguros) coordinating the delivery of primary healthcare services through the Portuguese community pharmacy network, founded as a joint venture between Grupo Ageas Portugal (Médis) and ANF. Its portfolio covers cardiology diagnostics (ECG/MAPA/Holter), cancer and diabetes screening, vaccinations, health parameter monitoring, injectable administration, medication delivery, and orthopedics services for accident victims, all designed to extend pharmacy-based preventive, diagnostic, and chronic disease management services reimbursed through the Médis insurance network.
Product overview
Go Far is a health services company formed as a joint venture between Grupo Ageas Portugal (via Médis) and the Associação Nacional das Farmácias (ANF). The company operates a platform of integrated primary healthcare services delivered through the Portuguese pharmacy network. The portfolio includes MCDT Cardiologia (cardiology diagnostics - ECG, MAPA, Holter), Campanha 50+ colorectal cancer screening, diabetes screening, vaccination services, health parameter monitoring, injectable administration, medication delivery, and orthopedic services. Go Far also manages the Rede Médis pharmacy network, enabling automatic reimbursement and preferential pricing for Médis insurance clients. Services are designed around three pillars: disease prevention, early diagnosis, and chronic disease management.
Differentiator
Problem solved
Functional benefit
Products and services
- MCDT Cardiologia
- Campanha 50+ (Rastreio Cancro Colorretal)
- Rastreio de Diabetes
Quantifiable outcome
- 4,190 participants screened in colorectal cancer campaign; 177 referred for medical follow-up; campaign implemented in 292 pharmacies
- +2 more outcomes
Companies that use Go Far
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Go Far technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Go Far partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- Alliance HealthcareminorAlliance Healthcare partnered with Go Far to supply first aid kits (Caixas de Primeiros Socorros) for Ocidental Seguros, distributed through pharmacies. This demonstrates Go Far's role as a coordination hub for pharmacy-based health services.
- Fundação AgeasminorFundação Ageas co-sponsored the Colorectal Cancer Awareness Campaign (50+), providing funding and institutional support. This is part of Grupo Ageas Portugal's broader corporate social responsibility initiatives.
- Fundação Millennium bcpminorFundação Millennium bcp co-sponsored the Colorectal Cancer Awareness Campaign (50+) as part of its social responsibility mission in health promotion and disease prevention.
- Fundação Calouste GulbenkianminorFundação Calouste Gulbenkian co-sponsored the Colorectal Cancer Awareness Campaign (50+), contributing to funding and health promotion efforts.
- Europacolon PortugalminorEuropacolon Portugal, a patient advocacy organization for colorectal cancer, partnered with Go Far on the Colorectal Cancer Awareness Campaign, contributing medical expertise and patient outreach.
- Médis — Serviços de Saúde, S.A. (subsidiary of Grupo Ageas Portugal)coreMédis is a co-founding shareholder of Go Far alongside ANF. The partnership enables Médis health insurance clients to access Go Far pharmacy services with automatic reimbursement. Médis provides the financing and insurance infrastructure, while Go Far coordinates service delivery through the pharmacy network.
- ANF — Associação Nacional das FarmáciascoreANF is a co-founding shareholder of Go Far alongside Médis. ANF provides access to its national pharmacy network (approximately 3,000 pharmacies), which Go Far leverages to deliver primary healthcare services. The partnership positions pharmacies as integrated health providers within the Médis insurance network.
Scale indicators10 records
Recent moves7 records
Expansion highlights4 records
Go Far competitors and assessment
Company assessmentEmerging players
- DocMorris: European online pharmacy and pharmacy services provider operating across several countries including Germany, the Netherlands, and Spain. Comparable to Go Far's pharmacy services and home medication delivery model, though focused on e-commerce rather than physical pharmacy network coordination.
Broad incumbents
- Humana Pharmacy Solutions: PBM arm of Humana managing pharmacy benefits and network administration for its insurance members. Comparable to Go Far in integrating insurance funding with pharmacy service delivery, though fully embedded within a major health insurer in the US market.
- MedImpact Healthcare Systems: Independent US PBM providing pharmacy benefit management and clinical programs to health plans, employers, and government programs. Comparable to Go Far as a PBM-like administrator coordinating insurance-funded pharmacy services, but at much larger scale and in a different regulatory context.
- OptumRx (UnitedHealth Group): One of the largest PBMs in the US, administering prescription drug benefits and pharmacy networks on behalf of health insurers and plan sponsors. Comparable to Go Far as a pharmacy network administrator integrating insurance funding with pharmacy-delivered services, though at vastly larger scale and in a different market.
- Express Scripts (Cigna): Major US PBM providing pharmacy benefit management, home delivery pharmacy, and network administration for health plans. Comparable to Go Far's combined PBM-adjacent function of managing insurance-reimbursed pharmacy services, but operates at much larger scale and scope.
- CVS Caremark: PBM and pharmacy services arm of CVS Health, managing drug benefits, pharmacy networks, and clinical services for insurers and employers. Comparable to Go Far in administering insurance-funded pharmacy services with integrated clinical offerings, though embedded in a much larger retail pharmacy and insurer ecosystem.
Others
- Alliance Healthcare (Walgreens Boots Alliance): Pharmaceutical wholesaler and distribution partner of Go Far in Portugal, distributing pharmacy products and operating healthcare-related services. Comparable as a pharmacy ecosystem participant and existing partner, though operating in wholesale distribution rather than network administration.
- McKesson Europe (Lloyds Pharmacy): Pharmaceutical distribution and pharmacy services company operating across Europe including pharmacy retail and clinical services. Comparable to Go Far as an ecosystem enabler in pharmacy healthcare delivery, though in distribution and broader pharmacy retail rather than network administration.
Regional players
- Boots UK: Large UK pharmacy chain delivering pharmacy-based primary care services including vaccinations, health monitoring, and chronic disease management, often in partnership with the NHS. Comparable to Go Far's model of extending pharmacy services beyond dispensing into primary care delivery, though in a different national market.
- Well Pharmacy (UK): UK pharmacy chain offering primary care services, vaccinations, and health monitoring through its network of pharmacies. Comparable to Go Far in delivering insurance/funder-funded primary healthcare services through a national pharmacy footprint, though in the UK market with NHS-aligned funding models.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Go Far financial estimates
Financial estimateRevenue estimate
Valuation estimate
Go Far leadership team
Management profileNumber of profiles
Profiles10 records
Go Far funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Go Far M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Go Far
What does Go Far do?
Go Far operates as an insurance mediator (Mediação de Seguros) coordinating the delivery of primary healthcare services through the Portuguese community pharmacy network, founded as a joint venture between Grupo Ageas Portugal (Médis) and ANF. Its portfolio covers cardiology diagnostics (ECG/MAPA/Holter), cancer and diabetes screening, vaccinations, health parameter monitoring, injectable administration, medication delivery, and orthopedics services for accident victims, all designed to extend pharmacy-based preventive, diagnostic, and chronic disease management services reimbursed through the Médis insurance network.
Is Go Far a public or private company?
Go Far is a private company. It is classified as corporate owned and is currently operating.
When was Go Far founded?
Go Far was founded in 2017. It employs 1 to 10 people.
Where is Go Far based?
Go Far is headquartered in Lisboa, Portugal, in the Europe region.
How does Go Far make money?
Two revenue lines are on record. Insurance Mediation Fees are the primary driver. The others are pharmacy Network Management Fees.
Who are Go Far's main competitors?
DocMorris is listed as an emerging player. Broad incumbents are Humana Pharmacy Solutions, MedImpact Healthcare Systems, OptumRx (UnitedHealth Group), Express Scripts (Cigna) and CVS Caremark. Others are Alliance Healthcare (Walgreens Boots Alliance) and McKesson Europe (Lloyds Pharmacy). Regional players are Boots UK and Well Pharmacy (UK).
Does Go Far have an API?
No public API is recorded for Go Far.
What industry is Go Far in?
Go Far's product category is Pharmacy-based Primary Healthcare Services. Its primary akta.pro industry code is HLAFALAI, Pharmacy Benefit Management (PBM) & Pharmacy Network Administration, with a secondary code of FSAIAFAN, Group Pharmacy Benefit (Rx) Coverage & PBM-Integrated Plans. Its NAICS code is 524292 and its SIC code is 6411.